|
RRAGA expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.52340000000906E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.98093000000066E-05 |
| Normal-vs-Stage2 |
2.364600E-01 |
| Normal-vs-Stage3 |
6.176400E-01 |
| Normal-vs-Stage4 |
1.533000E-01 |
| Stage1-vs-Stage2 |
5.559800E-01 |
| Stage1-vs-Stage3 |
4.474300E-02 |
| Stage1-vs-Stage4 |
8.664800E-01 |
| Stage2-vs-Stage3 |
2.490800E-01 |
| Stage2-vs-Stage4 |
7.802600E-01 |
| Stage3-vs-Stage4 |
2.544200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.11009999999878E-05 |
| Normal-vs-AfricanAmerican |
1.805960E-02 |
| Normal-vs-Asian |
9.379400E-01 |
| Caucasian-vs-AfricanAmerican |
4.513800E-01 |
| Caucasian-vs-Asian |
2.917600E-01 |
| AfricanAmerican-vs-Asian |
4.532800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.55620000014723E-07 |
| Normal-vs-Female |
4.165600E-01 |
| Male-vs-Female |
1.429900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.417700E-03 |
| Normal-vs-Extreme_Weight |
1.42219999998972E-06 |
| Normal-vs-Obese |
2.336600E-01 |
| Normal-vs-Extreme_Obese |
3.372400E-04 |
| Normal_Weight-vs-Extreme_Weight |
2.274600E-01 |
| Normal_Weight-vs-Obese |
3.707200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.713800E-01 |
| Extreme_Weight-vs-Obese |
5.478400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.525400E-01 |
| Obese-vs-Extreme_Obese |
6.205800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.760800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.920020E-03 |
| Normal-vs-Age(61-80Yrs) |
3.43149999970649E-07 |
| Normal-vs-Age(81-100Yrs) |
9.801000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.102000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.187800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.649900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.134200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.520800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.992800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.68629999997005E-06 |
| Normal-VS-Type2 PRCC |
1.257750E-03 |
| Normal-VS-KIRP CIMP |
2.550200E-02 |
| Normal-VS-Unclassified PRCC |
1.470399999981E-06 |
| Type1 PRCC-VS-Type2 PRCC |
7.358600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.856200E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.407200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.096300E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.021600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.857200E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.640700E-03 |
| Normal-vs-N1 |
9.513200E-01 |
| Normal-vs-N2 |
7.845100E-04 |
| N0-vs-N1 |
2.143200E-01 |
| N0-vs-N2 |
3.940000E-01 |
| N1-vs-N2 |
3.466100E-02 |
|
|
